Cargando…

Preclinical Study of DNA-Recognized Peptide Compound Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Progressive Renal Diseases in the Common Marmoset

Pyrrole-imidazole (PI) polyamides are novel gene silencers that strongly bind the promoter region of target genes in a sequence-specific manner to inhibit gene transcription. We created a PI polyamide targeting human TGF-β1 (hTGF-β1). To develop this PI polyamide targeting hTGF-β1 (Polyamide) as a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Otsuki, Masari, Fukuda, Noboru, Inoue, Takashi, Mineshige, Takayuki, Otsuki, Tomoyasu, Horikoshi, Shu, Endo, Morito, Abe, Masanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749436/
https://www.ncbi.nlm.nih.gov/pubmed/31480595
http://dx.doi.org/10.3390/molecules24173178
_version_ 1783452278392356864
author Otsuki, Masari
Fukuda, Noboru
Inoue, Takashi
Mineshige, Takayuki
Otsuki, Tomoyasu
Horikoshi, Shu
Endo, Morito
Abe, Masanori
author_facet Otsuki, Masari
Fukuda, Noboru
Inoue, Takashi
Mineshige, Takayuki
Otsuki, Tomoyasu
Horikoshi, Shu
Endo, Morito
Abe, Masanori
author_sort Otsuki, Masari
collection PubMed
description Pyrrole-imidazole (PI) polyamides are novel gene silencers that strongly bind the promoter region of target genes in a sequence-specific manner to inhibit gene transcription. We created a PI polyamide targeting human TGF-β1 (hTGF-β1). To develop this PI polyamide targeting hTGF-β1 (Polyamide) as a practical medicine for treating progressive renal diseases, we examined the effects of Polyamide in two common marmoset models of nephropathy. We performed lead optimization of PI polyamides that targeted hTGF-β1 by inhibiting in a dose-dependent manner the expression of TGF-β1 mRNA stimulated by PMA in marmoset fibroblasts. Marmosets were housed and fed with a 0.05% NaCl and magnesium diet and treated with cyclosporine A (CsA; 37.5 mg/kg/day, eight weeks) to establish chronic nephropathy. We treated the marmosets with nephropathy with Polyamide (1 mg/kg/week, four weeks). We also established a unilateral urethral obstruction (UUO) model to examine the effects of Polyamide (1 mg/kg/week, four times) in marmosets. Histologically, the renal medulla from CsA-treated marmosets showed cast formation and interstitial fibrosis in the renal medulla. Immunohistochemistry showed strong staining of Polyamide in the renal medulla from CsA-treated marmosets. Polyamide treatment (1 mg/kg/week, four times) reduced hTGF-β1 staining and urinary protein excretion in CsA-treated marmosets. In UUO kidneys from marmosets, Polyamide reduced the glomerular injury score and tubulointerstitial injury score. Polyamide significantly suppressed hTGF-β1 and snail mRNA expression in UUO kidneys from the marmosets. Polyamide effectively improved CsA- and UUO-associated nephropathy, indicating its potential application in the prevention of renal fibrosis in progressive renal diseases.
format Online
Article
Text
id pubmed-6749436
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67494362019-09-27 Preclinical Study of DNA-Recognized Peptide Compound Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Progressive Renal Diseases in the Common Marmoset Otsuki, Masari Fukuda, Noboru Inoue, Takashi Mineshige, Takayuki Otsuki, Tomoyasu Horikoshi, Shu Endo, Morito Abe, Masanori Molecules Article Pyrrole-imidazole (PI) polyamides are novel gene silencers that strongly bind the promoter region of target genes in a sequence-specific manner to inhibit gene transcription. We created a PI polyamide targeting human TGF-β1 (hTGF-β1). To develop this PI polyamide targeting hTGF-β1 (Polyamide) as a practical medicine for treating progressive renal diseases, we examined the effects of Polyamide in two common marmoset models of nephropathy. We performed lead optimization of PI polyamides that targeted hTGF-β1 by inhibiting in a dose-dependent manner the expression of TGF-β1 mRNA stimulated by PMA in marmoset fibroblasts. Marmosets were housed and fed with a 0.05% NaCl and magnesium diet and treated with cyclosporine A (CsA; 37.5 mg/kg/day, eight weeks) to establish chronic nephropathy. We treated the marmosets with nephropathy with Polyamide (1 mg/kg/week, four weeks). We also established a unilateral urethral obstruction (UUO) model to examine the effects of Polyamide (1 mg/kg/week, four times) in marmosets. Histologically, the renal medulla from CsA-treated marmosets showed cast formation and interstitial fibrosis in the renal medulla. Immunohistochemistry showed strong staining of Polyamide in the renal medulla from CsA-treated marmosets. Polyamide treatment (1 mg/kg/week, four times) reduced hTGF-β1 staining and urinary protein excretion in CsA-treated marmosets. In UUO kidneys from marmosets, Polyamide reduced the glomerular injury score and tubulointerstitial injury score. Polyamide significantly suppressed hTGF-β1 and snail mRNA expression in UUO kidneys from the marmosets. Polyamide effectively improved CsA- and UUO-associated nephropathy, indicating its potential application in the prevention of renal fibrosis in progressive renal diseases. MDPI 2019-09-01 /pmc/articles/PMC6749436/ /pubmed/31480595 http://dx.doi.org/10.3390/molecules24173178 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Otsuki, Masari
Fukuda, Noboru
Inoue, Takashi
Mineshige, Takayuki
Otsuki, Tomoyasu
Horikoshi, Shu
Endo, Morito
Abe, Masanori
Preclinical Study of DNA-Recognized Peptide Compound Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Progressive Renal Diseases in the Common Marmoset
title Preclinical Study of DNA-Recognized Peptide Compound Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Progressive Renal Diseases in the Common Marmoset
title_full Preclinical Study of DNA-Recognized Peptide Compound Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Progressive Renal Diseases in the Common Marmoset
title_fullStr Preclinical Study of DNA-Recognized Peptide Compound Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Progressive Renal Diseases in the Common Marmoset
title_full_unstemmed Preclinical Study of DNA-Recognized Peptide Compound Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Progressive Renal Diseases in the Common Marmoset
title_short Preclinical Study of DNA-Recognized Peptide Compound Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Progressive Renal Diseases in the Common Marmoset
title_sort preclinical study of dna-recognized peptide compound pyrrole-imidazole polyamide targeting human tgf-β1 promoter for progressive renal diseases in the common marmoset
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749436/
https://www.ncbi.nlm.nih.gov/pubmed/31480595
http://dx.doi.org/10.3390/molecules24173178
work_keys_str_mv AT otsukimasari preclinicalstudyofdnarecognizedpeptidecompoundpyrroleimidazolepolyamidetargetinghumantgfb1promoterforprogressiverenaldiseasesinthecommonmarmoset
AT fukudanoboru preclinicalstudyofdnarecognizedpeptidecompoundpyrroleimidazolepolyamidetargetinghumantgfb1promoterforprogressiverenaldiseasesinthecommonmarmoset
AT inouetakashi preclinicalstudyofdnarecognizedpeptidecompoundpyrroleimidazolepolyamidetargetinghumantgfb1promoterforprogressiverenaldiseasesinthecommonmarmoset
AT mineshigetakayuki preclinicalstudyofdnarecognizedpeptidecompoundpyrroleimidazolepolyamidetargetinghumantgfb1promoterforprogressiverenaldiseasesinthecommonmarmoset
AT otsukitomoyasu preclinicalstudyofdnarecognizedpeptidecompoundpyrroleimidazolepolyamidetargetinghumantgfb1promoterforprogressiverenaldiseasesinthecommonmarmoset
AT horikoshishu preclinicalstudyofdnarecognizedpeptidecompoundpyrroleimidazolepolyamidetargetinghumantgfb1promoterforprogressiverenaldiseasesinthecommonmarmoset
AT endomorito preclinicalstudyofdnarecognizedpeptidecompoundpyrroleimidazolepolyamidetargetinghumantgfb1promoterforprogressiverenaldiseasesinthecommonmarmoset
AT abemasanori preclinicalstudyofdnarecognizedpeptidecompoundpyrroleimidazolepolyamidetargetinghumantgfb1promoterforprogressiverenaldiseasesinthecommonmarmoset